Navigation Links
Minnesota Supreme Court Confirms that Minnesota's Statutes of Limitations Govern Out-of-State Claims
Date:9/5/2009

On September 2, 2009, the Minnesota Supreme Court held that Minnesota’s statute of limitations would govern all personal injury claims properly brought in Minnesota courts. In Fleeger v. Wyeth (A08-2124), the federal district court in Little Rock, Arkansas presiding over the hormone therapy MDL proceedings certified a question to the Minnesota Supreme Court as to whether Minnesota’s statutes of limitations would govern the claims of out-of-state plaintiffs who sued out-of-state defendants for claims that accrued elsewhere. Erik Walker, an attorney at Hissey Kientz, LLP in Austin, Texas, principally authored the brief and argued the case for the plaintiff.

(Vocus) September 5, 2009 -- On September 2, 2009, the Minnesota Supreme Court held that Minnesota’s statute of limitations would govern all personal injury claims properly brought in Minnesota courts. In Fleeger v. Wyeth (A08-2124), the federal district court in Little Rock, Arkansas presiding over the hormone therapy MDL proceedings certified a question to the Minnesota Supreme Court as to whether Minnesota’s statutes of limitations would govern the claims of out-of-state plaintiffs who sued out-of-state defendants for claims that accrued elsewhere.

Minnesota’s highest court answered "yes," upholding longstanding state precedent finding that statutes of limitations are procedural in nature, therefore the law of the forum governs all claims in which personal jurisdiction is present in Minnesota. In doing so, the court noted that the state’s 2004 Uniform Conflict of Law-Limitations Act already mandated that choice of law principles would determine the applicable law for claims accruing after August 1, 2004. At issue was the law that would apply to claims accruing before that date. Minnesota’s highest court confirmed that Minnesota law would govern such claims.

Erik Walker, an attorney at Hissey Kientz, LLP in Austin, Texas, principally authored the brief and argued the case for the plaintiff. Walker lauded the court’s decision: "In 2004, when the legislature abrogated the "law of the forum" doctrine, it decided that the change in law should not apply retroactively, to victims whose claims had already accrued and who may have relied on Minnesota’s longstanding precedent."

"The legislature consciously exempted claims accruing before the effective date of the act, and the court in Fleeger respected that decision," Walker said. "As a result, thousands women who acquired breast cancer from hormone therapy, along with plaintiffs in many other litigations, may continue to prosecute their claims to justice."

About Hissey Kientz, LLP
Hissey Kientz, LLP represents individuals who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by a fentanyl or Duragesic overdose, acute phosphate nephropathy as a result of Fleet Phospho-soda products, Digitek, Zicam, the Composix Kugel mesh patch, gadolinium MRI contrast dyes, Reglan, FELA railroad injury lawsuits, Raptiva, the Ortho Evra patch, Fen-Phen or "herbal Fen-Phen" products containing ephedra or ma huang, as well as other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases/hormone-therapy-lawsuit/minnesota-supreme-court/prweb2837374.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Seasonal Flu Vaccinations Available Now at Target Clinics in Minnesota
2. Childrens Hospitals and Clinics of Minnesota Welcomes Twin Cities Businesswoman Molly Culligan to its Board of Directors
3. Minnesota Health Improvement Leaders Honored
4. American Lung Association in Minnesota: Motorists Can Get 85 Cents a Gallon E85 Fuel in Woodbury, Minn.
5. New Study of House Health Reform Bill: Minnesota Faces Over $654 Million in Medicare-Funded Nursing Home Cuts Over Ten Years
6. New Study of House Health Reform Bill: Minnesota Faces Over $654 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
7. Availity Teams with Blue Cross and Blue Shield of Minnesota to Improve Health Care Efficiencies
8. ClearWay Minnesota(SM) Adds New Director of Research
9. Dr. Wilhelm, First Minnesota Cosmetic Dentist to Offer WOW Spraywhite Teeth Whitening
10. Class Action Notice for Minnesota Light Cigarette Litigation From Lommen, Abdo, Cole, King & Stageberg, P.A.
11. Childrens Hospitals and Clinics of Minnesota Receive Level III Trauma Designation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Minnesota Supreme Court Confirms that Minnesota's Statutes of Limitations Govern Out-of-State Claims
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Researchers can ... so routine. A fresh look at this technique may yield big benefits. Scientists ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of contamination ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... 2016 , ... Hadley Institute for the Blind and Visually ... or visually impaired, announces the election of Julie S. Tye as its next ... of Trustees retained Morris & Berger, a firm specializing in non-profit executive searches, ...
(Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... ... the company’s top management team to meet the needs of its recent and ... to drive continued growth and business development across widening market segments. Max joined ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
Breaking Medicine Technology: